SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-003183
Filing Date
2022-01-31
Accepted
2022-01-31 16:03:58
Documents
12
Period of Report
2022-01-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K - 1-31-22 RESIGNATION kdny-8k_20220126.htm   iXBRL 8-K 34907
  Complete submission text file 0001564590-22-003183.txt   163366

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kdny-20220126.xsd EX-101.SCH 5697
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20220126_lab.xml EX-101.LAB 19422
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20220126_pre.xml EX-101.PRE 11585
6 EXTRACTED XBRL INSTANCE DOCUMENT kdny-8k_20220126_htm.xml XML 3563
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 22573947
SIC: 2834 Pharmaceutical Preparations